Skip to main content
大唐药业 logo

大唐药业 — Investor Relations & Filings

Ticker · 920433 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 420 across all filing types
Latest filing 2025-07-13 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920433

About 大唐药业

http://www.nmdt.com.cn/

Inner Mongolia Datang Pharmaceutical specializes in the research, development, and production of traditional Chinese and Mongolian medicines. The company focuses on modernizing ethnic medicinal formulas through advanced biotechnology and standardized manufacturing processes. Its product portfolio covers therapeutic areas including respiratory health, cardiovascular conditions, and gastrointestinal disorders. Notable offerings include Xuanfei Zhike granules and specialized Mongolian medicinal preparations. The organization integrates traditional knowledge with contemporary clinical research to develop proprietary formulations. By maintaining rigorous quality management systems and investing in automated production lines, the company aims to enhance the efficacy and accessibility of ethnic medicines for a broad patient base.

Recent filings

Filing Released Lang Actions
投资者关系活动记录表
Regulatory Filings Classification · 95% confidence The document is an investor relations activity record from Inner Mongolia Datang Pharmaceutical Co., Ltd. It details a specific investor relations event held on July 11, 2025, including questions and answers about the company's R&D progress, future plans, product updates, and a note about the upcoming half-year report to be disclosed on August 27, 2025. The document does not contain actual financial statements or detailed financial data but rather a summary of investor Q&A and event details. It is not an earnings release or interim report itself, but an investor relations activity record. This type of document fits best under Regulatory Filings (RNS) as it is a general regulatory announcement and does not fit other specific categories.
2025-07-13 Chinese
关于参加内蒙古辖区2025年投资者网上集体接待日活动预告公告
Investor Presentation Classification · 90% confidence The document is a short announcement (785 characters) about the company's participation in an investor online collective reception day event organized by regulatory and industry bodies. It includes details about the event type, time, location, participants, and contact information. It mentions that company executives will discuss the 2024 annual performance and other topics during the event. However, the document itself does not contain any financial statements, detailed financial data, or the actual report. It is a notice about an upcoming investor presentation event rather than the presentation or report itself. Given the short length and nature of the content, this fits best as an Investor Presentation (IP) announcement or a Regulatory Filing (RNS). Since it is announcing participation in an investor event with planned discussion of financial results, the best fit is Investor Presentation (IP).
2025-07-08 Chinese
2024年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is titled as an 'Annual Equity Distribution Implementation Announcement' for the year 2024 by Inner Mongolia Datang Pharmaceutical Co., Ltd. It details the dividend distribution plan, including the cash dividend amount, tax withholding policies, record date, ex-dividend date, and payment method. It references the shareholders' meeting resolution approving the plan. The document is short (1250 characters) and primarily announces the dividend distribution details rather than providing a full financial report or detailed analysis. This fits the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and details for shareholders.
2025-05-22 Chinese
内蒙古上都律师事务所关于内蒙古大唐药业股份有限公司2024年年度股东会法律意见书
Regulatory Filings
2025-05-18 Chinese
2024年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2024 Annual General Meeting Resolution Announcement" for Inner Mongolia Datang Pharmaceutical Co., Ltd. It details the convening and attendance of the shareholders' meeting, the voting results on various proposals including the 2024 annual board work report, supervisory board report, independent directors' report, equity distribution plan, annual report and financial statements, budget report, credit application, use of idle funds, auditor appointment, and accounting policy changes. The document includes legal opinions confirming the legality of the meeting and voting procedures. The content is focused on the resolutions passed at the annual shareholders' meeting rather than the full annual report itself. The document length is 3117 characters, which is relatively short and consistent with a meeting resolution announcement rather than a full report. Therefore, this document is best classified as a Declaration of Voting Results & Voting Rights Announcements (DVA).
2025-05-18 Chinese
投资者关系活动记录表
Call Transcript Classification · 95% confidence The document is titled as an "投资者关系活动记录表" (Investor Relations Activity Record) and specifically mentions an "业绩说明会" (performance explanation meeting) held on May 13, 2025, regarding the 2024 annual report. The content includes detailed Q&A about the company's 2024 financial performance, business trends, R&D projects, and future outlook. This matches the characteristics of a Call Transcript (CT) or an Investor Presentation (IP). However, the format is a transcript of a Q&A session during an earnings or annual report explanation meeting, not a presentation slide deck. It is not a full Annual Report (10-K) or Interim Report (IR) because it does not contain full financial statements but detailed management responses to investor questions. The document length is 2165 characters, which is short but contains substantive Q&A content. Therefore, the best fit is Call Transcript (CT).
2025-05-13 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.